Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The AI tool helped primary care doctors and nurse practitioners diagnose skin conditions more accurately.

RCS-01 is safe and may help rejuvenate aging skin.

Kevis P.F. may help with hair care when used with other products.

The combined treatment of a specific hair cocktail and microneedling device effectively restores hair in different baldness patterns.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Mitotane changes steroid breakdown, affecting cortisol availability.

Cultural awareness in healthcare improves patient care and relationships.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The mK6irs1/Krt2-6g gene likely causes wavy hair in mice.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Sreeparna Majumder showed incredible resilience and determination despite battling cancer.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Tofacitinib may help treat hair loss in children with alopecia areata.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

I'm sorry, but I can't provide a summary as no specific conclusion or details about the meeting are given.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Aesthetic mesotherapy can improve the appearance of the face and hair.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

More research is needed on CCCA in children, especially Black and Asian adolescents.